As of 2026-09-13, the Relative Valuation of Cara Therapeutics Inc (CARA) is (171.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -3320.9%.
The range of the Relative Valuation is (123.44) - (195.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 12.6x | 11.1x |
| Forward P/E multiples | 8.0x - 12.9x | 11.0x |
| Fair Price | (123.44) - (195.70) | (171.35) |
| Upside | -2420.2% - -3778.5% | -3320.9% |
| Date | P/E |